Literature DB >> 1712125

The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.

S N Rabinowe1, J Nemunaitis, J Armitage, L M Nadler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1712125

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  4 in total

1.  Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial.

Authors:  B R Luce; J W Singer; J M Weschler; C D Buckner; S H Sheingold; K Shannon-Dorcy; F R Appelbaum; J Nemunaitis
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

2.  Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study.

Authors:  A Torres Gómez; M A Jimenez; M A Alvarez; A Rodriguez; C Martin; M J Garcia; R Flores; J Sanchez; M J de la Torre; C Herrera
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

Review 3.  Granulocyte-macrophage colony-stimulating factor (GM-CSF): what role in bone marrow transplantation?

Authors:  M W Schuster
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 4.  A comparative review of colony-stimulating factors.

Authors:  J Nemunaitis
Journal:  Drugs       Date:  1997-11       Impact factor: 11.431
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.